Problems when using vacuum blood collection tubes with low-speed centrifuges

Release time:

2012-12-11


Overview:

The routine use of vacuum tubes offers significant benefits in enhancing the quality of testing, preventing biosafety contamination, standardizing blood-drawing techniques, and improving operational efficiency. At the same time, however, it is essential to pay close attention to the selection of high-quality tubes, adhere to standardized operating procedures, and promptly address any issues that may arise during use.

  1. Selection of vacuum blood collection tubes: The selection should be guided by the principles of safety, effectiveness, high quality at a reasonable price, ensuring stable and accurate test results, and reducing the financial burden on patients. Currently, while the quality of some small-scale manufacturers still fails to meet usage requirements, many domestically produced brands have already reached or even surpassed the quality standards of comparable imported products—and they offer significant cost advantages, thereby substantially lowering medical expenses for patients. Therefore, we should not blindly pursue or rely solely on imported products; domestic brands that offer good quality at favorable prices are equally capable of meeting the demands of routine clinical applications. However, before putting these tubes into formal clinical use, it is essential to conduct pilot tests and evaluations using small sample sizes (at least 100 cases) for each type of vacuum blood collection tube. Only after such trials and evaluations can they be officially adopted in clinical practice.

  2. The recommended order for blood collection is as follows: clotting tube (serum tube) → sodium citrate tube → heparin or EDTA tube → potassium oxalate and sodium fluoride tube → erythrocyte sedimentation rate tube. The primary reason is that the first tube often contains anticoagulant solution, which can easily induce clotting and is therefore unsuitable for coagulation assays.

  3. During blood collection, the patient should be relaxed and the environment kept warm to prevent venous spasm. The tourniquet should not be applied for too long, and tapping or slapping the arm is strictly prohibited, as this could lead to local blood concentration or activation of the coagulation system. It is important to monitor whether the blood collection process is smooth and whether the collected blood volume meets the required specifications. Due to the continuous increase in laboratory sample volumes, the speed of traditional laboratory serum separation significantly lags behind that of fully automated analyzers. This discrepancy arises because the rate of blood clotting is closely related to the activating properties of glass and plastic tubes as well as to temperature. Experiments have shown that coagulation factors XI and XII are activated upon contact with the inner walls of glass tubes. Typically, under room temperature conditions of 23–25°C, most of the blood clots within 30 minutes after collection, and complete clotting usually takes about 1 hour. However, when blood comes into contact with the hydrophobic walls of plastic tubes, the activation of coagulation factors XI and XII is markedly reduced, and it may take 2–4 hours for the blood to fully clot. This delay adversely affects the efficiency of serum separation. To address these issues, a blood-clotting accelerator can be sprayed onto the inner surface of the blood collection tubes. After blood collection, gently invert the tube 4–5 times to mix the blood thoroughly, then place the tube upright at room temperature until the blood has completely clotted. Once the blood has clotted, centrifuge the tube. If the blood shows signs of contraction and serum leakage becomes visible, it confirms that the blood has fully clotted.

  4. Requirements for Centrifugation of Serum Separation Gel–Promoted Coagulation Tubes: To prepare high-quality serum specimens using separation gel–promoted coagulation tubes, two critical steps—complete blood clotting and proper centrifugation conditions—are essential. For centrifugation using a horizontal centrifuge, the specific operational steps are as follows: Immediately after blood collection, gently invert the blood collection tube 4–5 times to thoroughly mix the specimen. Allow the specimen to sit undisturbed for 30 minutes to ensure complete clotting. Set the centrifugation radius at 8 cm and maintain the centrifugal speed between 3,500 and 4,000 rpm for 10 minutes. During this process, the serum will be completely separated from the blood clot by the separation gel. The serum specimen can then be directly used for instrument analysis or transferred into the instrument’s dedicated sample cups. Only under these conditions can high-quality serum specimens be prepared. A good performance of the separation gel depends on adequate centrifugation speed; if the centrifugation speed is too low, the force acting on the separation gel will be insufficient, leading to poor separation of the gel. Additionally, if the blood has not fully clotted before centrifugation, fibrin clots may remain suspended in the serum or within the gel layer, potentially causing hemolysis. Except in emergency situations, it is generally best to centrifuge blood samples only after they have completely clotted, as this yields superior separation results. Due to lack of experience, such phenomena often occur when laboratories first begin using separation gel–promoted coagulation tubes. If fibrin strands remain suspended in the serum, they can easily clog the blood-collection needles of automated analyzers. Currently, the quality of many domestically produced separation gels has reached or even approached international standards. Usage data from numerous hospitals indicate that the separation time and efficiency of these domestic separation gels (such as those manufactured by Youli) are virtually indistinguishable from those of comparable products from companies like BD in the U.S. A study was conducted to evaluate whether using domestically produced (Youli) separation gel–promoted plastic tubes affects the measured values for more than 30 biochemical and immunological parameters. The study compared these tubes with standard glass tubes and with similar products from BD in the U.S., and the results showed excellent comparability between the two types of tubes, with no statistically significant differences observed (all p > 0.05).

  5. The ratio of blood to anticoagulant must be precise. The absolute amount of anticoagulant in the blood sample can alter the concentration of calcium ions in the plasma, thereby affecting the experimental results. The higher the absolute concentration of calcium, the shorter the PT and APTT clotting times. Regarding the “dead space” issue in vacuum tubes used for coagulation testing, experiments have shown that the dead space in these tubes can lead to enhanced platelet activity (increased PF4 activity) and a shortened APTT. The causes underlying this phenomenon are multifactorial. Since the activation of platelets by the dead space is a random and occasional event, the underlying mechanisms and the associated probabilities remain unclear at present. Consequently, when conducting platelet function tests and monitoring APTT to guide heparin anticoagulation therapy, deviations in the experimental results may occur.

  In summary, the routine use of vacuum tubes offers significant benefits in enhancing the quality of examinations, preventing biosafety contamination, standardizing blood-drawing techniques, and improving operational efficiency. However, it is equally crucial to pay close attention to the selection of high-quality tubes, adhere to standardized procedures, and promptly address any issues that may arise during operation.